Intervention Group 2 for Prostate Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Prostate CancerEducation Materials for MyProstateScore - Other
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This is a national-level research study of urologists. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

6 Primary · 0 Secondary · Reporting Duration: [4 months]

[4 months]
CPV-measured change in treatment Quality
CPV-measured differences in cost of care between control and intervention arms
CPV-measured rate of adoption for MyProstateScore
CPV-measured variation in evidence based decisions between control and intervention arms
CPV-measured variation in evidence based decisions between intervention arms
Clinical Performance and Value (CPV)-measured variation in Assessment

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Control Group
1 of 3
Intervention Group 2
1 of 3
Intervention Group 1
1 of 3

Active Control

Experimental Treatment

249 Total Participants · 3 Treatment Groups

Primary Treatment: Intervention Group 2 · No Placebo Group · N/A

Intervention Group 2
Other
Experimental Group · 1 Intervention: Education Materials for MyProstateScore · Intervention Types: Other
Intervention Group 1
Other
Experimental Group · 1 Intervention: Education Materials for MyProstateScore · Intervention Types: Other
Control GroupNoIntervention Group · 1 Intervention: Control Group · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: [4 months]

Who is running the clinical trial?

Qure Healthcare, LLCLead Sponsor
19 Previous Clinical Trials
3,993 Total Patients Enrolled
1 Trials studying Prostate Cancer
217 Patients Enrolled for Prostate Cancer

Eligibility Criteria

Age Any Age · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a board-certified urologist for at least two years.
You are a doctor or other health professional who is responsible for the care of patients in a hospital or other health care facility.
Evaluate patients at risk for prostate cancer in their practice.